The Ultimate Guide to a Life Sciences IPO
The life sciences industry is in the middle of an IPO boom, with the 10 highest-valued biotech IPOs raising $3.
Meet Kelly Provost: A Leader in CFGI’s Life Sciences Capital Markets
Kelly Provost is a leader in CFGI’s Life Sciences Capital Markets practice and has dedicated her career to supporting companies that are trying to cure diseases and save lives, making a difference in the lives of people across the world.
Meet Melanie Kavanagh: A Committed Accounting and Finance Leader at CFGI’s SF Office
Melanie Kavanagh’s promotion to Partner has been an achievement in the making since the day she walked in the doors at CFGI in 2012.
Whitepaper: Private Equity – Current and emerging financial due diligence considerations when acquiring physician practices
As PE acquisitions of healthcare businesses have surged over the past decade, investments in physician practices and physician practice management (PPM) companies have accelerated apace.